Your browser doesn't support javascript.
loading
In Response to: 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?' by Ostler et al. and 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No' by Macbeth and Hughes-Davies.
Phillips, I; Olson, R; Palma, D; Harrow, S.
Afiliación
  • Phillips I; Edinburgh Cancer Centre, Edinburgh, UK; Edinburgh Cancer Research UK Centre, Edinburgh, UK. Electronic address: iain.phillips@nhslothian.scot.nhs.uk.
  • Olson R; Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada.
  • Palma D; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Harrow S; Edinburgh Cancer Centre, Edinburgh, UK; Edinburgh Cancer Research UK Centre, Edinburgh, UK.
Clin Oncol (R Coll Radiol) ; 34(4): e169-e170, 2022 04.
Article en En | MEDLINE | ID: mdl-35148914
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiocirugia / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiocirugia / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article